Doctor profile · Federal record
Dr. Raman Sood, M.D.
Medical Oncology Physician (CMS: Medical Oncology) · Dunkirk, NY
- NPI 1740272459
- Accepts Medicare
- MIPS 94.9 / 100 · 2023
- 37 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
617 Central Ave
Dunkirk, NY 140482529
(716) 366-1223
fax (716) 366-6844
Credentials & registration
- NPI registered
- August 2005 — 21 yrs on file
- Profile last updated
- April 30, 2012
- Year of graduation
- 1989 — 37 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- New York #219466-1
- Medicaid
- NY #01771695
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1740272459. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
13,949
Distinct HCPCS
10
Medicare allowed
$136,244
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1453 |
Injection, fosaprepitant, 1 mg | 8,050 | 11 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,812 | 24 | $0 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 832 | 13 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 740 | 15 | $1 | |
36415 |
Insertion of needle into vein for collection of blood sample | 556 | 172 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 417 | 173 | $86 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 289 | 119 | $122 | |
96375 |
Injection of additional new drug or substance into vein | 242 | 28 | $15 | |
J7050 |
Infusion, normal saline solution, 250 cc | 198 | 28 | $1 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 186 | 27 | $126 |
In context: peer comparison
Among 1 peers in Dunkirk Medical Oncology Physician, average services per provider: 664. This provider delivers 21× the peer median.Open Payments
Industry payments received
All-time total
$29,133
Transactions
105
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 17 | $23,124.85 | |
| AstraZeneca Pharmaceuticals Lp | 20 | $3,996.35 | |
| Merck Sharp & Dohme LLC | 11 | $226.93 | |
| Janssen Biotech, INC. | 10 | $202.46 | |
| Novartis Pharmaceuticals Corporation | 9 | $166.92 | |
| Pfizer INC. | 7 | $148.69 | |
| GlaxoSmithKline, LLC. | 5 | $103.75 | |
| Takeda Pharmaceuticals U.S.A., INC. | 3 | $101.88 | |
| Rigel Pharmaceuticals, INC. | 1 | $95.26 | |
| Astellas Pharma US INC | 5 | $94.94 | |
| Celgene Corporation | 4 | $77.33 | |
| Genentech USA, INC. | 4 | $75.35 | |
| Lilly USA, LLC | 3 | $67.09 | |
| Daiichi Sankyo INC. | 3 | $58.51 | |
| Incyte Corporation | 3 | $57.54 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
819
Patients
193
Total drug cost
$2,211,578
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 227 | 57 | $7,535 |
| Prednisone | Generic | 71 | 18 | $482 |
| Anastrozole | Generic | 61 | 15 | $1,591 |
| Venclexta (Venetoclax) | Brand | 58 | 0 | $515,632 |
| Hydroxyurea | Generic | 56 | 13 | $2,333 |
| Dexamethasone | Generic | 55 | 21 | $1,162 |
| Ondansetron Odt (Ondansetron) | Brand | 51 | 28 | $634 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 47 | 0 | $802,810 |
| Acyclovir | Generic | 45 | 12 | $474 |
| Levofloxacin | Generic | 33 | 16 | $149 |
Hospital affiliations
Frequently asked questions
What is Dr. Raman Sood's medical specialty?
Dr. Raman Sood practices Medical Oncology Physician in Dunkirk, NY.
Where does Dr. Raman Sood practice?
Dr. Raman Sood practices at 617 Central Ave, Dunkirk, NY 140482529. Office phone: 7163661223.
What is Dr. Raman Sood's NPI?
Dr. Raman Sood's National Provider Identifier (NPI) is 1740272459, issued by NPPES.
Does Dr. Raman Sood accept Medicare assignment?
Yes. Dr. Raman Sood accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Raman Sood commonly perform?
Top Medicare-reported procedures in 2023: Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, dexamethasone sodium phosphate, 1 mg (HCPCS J1100); Injection, ondansetron hydrochloride, per 1 mg (HCPCS J2405). Source: CMS Medicare Physician & Other Practitioners file.